Skip to main content
. 2019 Oct 14;7(10):1345–1352. doi: 10.1177/2050640619883704

Table 6.

Results of Questions 14 and 15 and comparison with the previous survey. In all comparisons p > 0.05.

Question 14
Current survey (n = 588) Previous survey (n = 380)
You believe that biosimilars (Generic: a drug product that is comparable to brand/reference listed drug product in dosage form, strength, route of administration, quality and performance characteristics, and intended use, containing the same active ingredients): (a) Are like generic drugs 152 25.9% 116 (30.6%)
(b) Are close to generic drugs 175 29.8% 127 (33.3%)
(c) Are not at all like generics 149 25.3% 69 (18.2%)
(d) You don’t know 112 19.1% 68 (17.9%)
Question 15
Current survey (n = 589) Previous survey (n = 379)
Regarding generic treatments: (Generic: a drug product that is comparable to brand/reference listed drug product in dosage form, strength, route of administration, quality and performance characteristics, and intended use, containing the same active ingredients): (a) You take them without worries 227 38.5% 126 (33.3%)
(b) You accept to take them but you have some doubts 208 35.3% 128 (33.8%)
(c) You refuse them when you can 97 16.5% 78 (20.6%)
(d) You have never thought about this 28 4.8% 30 (7.9%)
(e) You don’t know 29 4.9% 17 (4.5%)